OpenVSafe by OpenVAERS
Search V-safe

BU7-62469-74443

3 vaccinations 4 coded responses 10 check-ins 4 free-text entries 2 call cases
Sex
Female
Age at first dose
56-60
ZIP prefix
315 / GA
Registered
2021-03-19
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-19
    Registered in v-safe
  2. 2021-03-19
    Dose 1 — Pfizer-BioNTech
  3. 2021-03-21
    Survey response — days 1–6 daily, dose 1
    MedDRA: Headache, Injection site pain, Injection site pruritus, Tenderness — Feeling: Good · Rash, not including the immediate area around the injection site
    Free text: First day pain at injection site, headache and itching. Second day just tender and no itching or headache. Third day no pain.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-03-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  5. 2021-03-23
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-03-26
    Health check-in — day 7, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-04-02
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  8. 2021-04-12
    Dose 2 — Pfizer-BioNTech
  9. 2021-04-16
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Chills, Fatigue or tiredness, Nausea
    Adult check-in
  10. 2021-04-26
    Survey response — day 14, dose 2
    MedDRA: Meningitis — Feeling: Poor · Be unable to work
    Free text: Meningitis
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  11. 2021-08-20
    Dose 3 — Pfizer-BioNTech
  12. 2021-10-11
    Survey response — 6 months, dose 2
    MedDRA: Drug hypersensitivity, Hepatic enzyme increased, Impaired healing, Skin ulcer — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit
    Free text: Issues with toe ulcers that will not heal. Allergic reactions to antibiotics never experienced before. In addition, elevated liver counts. All issues - doctors have been unable to determine root cause.
    MedDRA releases: 2024-11 · check-in free text available
  13. 2021-10-11
    Report sent to call center — 6 months, dose 2
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
  14. 2021-10-12
  15. 2022-02-18
    Survey response — 6 months, dose 3
    MedDRA: Angiopathy, Unevaluable event, Vascular occlusion, Vascular pain — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Vasculopathy - undetermined cause limiting mobility and reflecting blockage, pain and inflammation.
    MedDRA releases: 2024-11 · check-in free text available
  16. 2022-02-18
    Report sent to call center — 6 months, dose 3
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  17. 2022-02-21
    Call successful
    Does not wish to fill out VAERS report
  18. 2022-08-22
    Health check-in — 12 months, dose 3
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-03-19Pfizer-BioNTech
22021-04-12Pfizer-BioNTech
32021-08-20Pfizer-BioNTech No

Call center

2 call center cases

2 successful

See the call center timeline

Free text

Release 6 — days 1–6 daily, dose 1

2021-03-21

Systemic reaction (other): First day pain at injection site, headache and itching. Second day just tender and no itching or headache. Third day no pain.

Release 8 — day 14, dose 2

2021-04-26

Symptoms: Meningitis

Release 10 — 6 months, dose 2

2021-10-11

Symptoms: Issues with toe ulcers that will not heal. Allergic reactions to antibiotics never experienced before. In addition, elevated liver counts. All issues - doctors have been unable to determine root cause.

Release 11 — 6 months, dose 3

2022-02-18

Symptoms: Vasculopathy - undetermined cause limiting mobility and reflecting blockage, pain and inflammation.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAngiopathy · · ✓
SDDrug hypersensitivity · · ✓
SDHepatic enzyme increased · · ✓
SDImpaired healing · · ✓
SDMeningitis ✓ ✓ ✓
SDSkin ulcer · · ✓
SDUnevaluable event · · ✓
SDVascular occlusion · · ✓
SDVascular pain · · ✓
SROHeadache ✓ ✓ ✓
SROInjection site pain ✓ ✓ ✓
SROInjection site pruritus ✓ ✓ ✓
SROTenderness ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release